897019-55-5 Usage
Uses
Used in Pharmaceutical Development:
3-Propoxy-azetidine hydrochloride is used as a chemical intermediate for the synthesis of various pharmaceutical compounds, particularly those targeting psychiatric and neurological disorders. Its unique structure allows for the development of new drugs with potential therapeutic benefits in these areas.
Used in Chemical Research:
In the field of chemical research, 3-Propoxy-azetidine hydrochloride is used as a reagent and a building block for the synthesis of complex organic molecules. Its properties make it a valuable tool for understanding the synthesis and reactions of various organic compounds.
Used in Neurological Research:
3-Propoxy-azetidine hydrochloride is used as a research compound in the study of the central nervous system. Its potential effects on the CNS and its psychoactive properties are of interest to scientists seeking to understand and develop treatments for neurological disorders.
Used in Drug Discovery:
As a target for drug discovery, 3-Propoxy-azetidine hydrochloride is utilized to identify and develop new therapeutic agents with novel mechanisms of action. Its unique properties and potential applications in treating psychiatric and neurological disorders make it an attractive candidate for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 897019-55-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,7,0,1 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 897019-55:
(8*8)+(7*9)+(6*7)+(5*0)+(4*1)+(3*9)+(2*5)+(1*5)=215
215 % 10 = 5
So 897019-55-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO.ClH/c1-2-3-8-6-4-7-5-6;/h6-7H,2-5H2,1H3;1H
897019-55-5Relevant articles and documents
AZETIDINE-SUBSTITUTED PYRAZOLINES AS PAR-1 ANTAGONISTS
-
Page/Page column 56, (2008/06/13)
The invention relates to blood clotting, and especially to the use of azetidine-substituted pyrazolines as medicaments, novel azetidine-substituted pyrazolines, methods for the production thereof, and the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases, preferably thromboembolic diseases.